Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
muromonab t-cell surface glycoprotein cd3 zeta chain biotech NA drugbank , DGIDB Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 15.91 approved,investigational unknown
muromonab t-cell surface glycoprotein cd3 delta chain biotech NA drugbank , DGIDB Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 9.09 approved,investigational unknown
muromonab t-cell surface glycoprotein cd3 epsilon chain biotech NA drugbank , DGIDB Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 12.73 approved,investigational binder
muromonab t-cell surface glycoprotein cd3 epsilon NA Successful target TTD , DGIDB Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 12.73 approved unknown
muromonab t-cell surface glycoprotein cd3 gamma chain biotech NA drugbank , DGIDB Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.9 approved,investigational unknown
muromonab low affinity immunoglobulin gamma fc region receptor iii-b biotech NA drugbank Transplanted organ[MeSHID:D019737]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
click here to return to the previous page